Abstract:Background: Human amniotic mesenchymal stem cells (hAMSCs) derived from amniotic membrane have multilineage differentiation, immunosuppressive, and anti -inflammation which makes them suitable for the treatment of various diseases. Objective: This study aimed to explore the therapeutic effect and molecular mechanism of hAMSCs in ventricular remodeling (VR). Methods: hAMSCs were characterized by a series of experiments such as flow cytometric analysis, immunofluorescence, differentiative induction and tumorigenicity. Mouse VR model was induced by isoproterenol (ISO) peritoneally, and the therapeutic effects and the potential mechanisms of hAMSCs transplantation were evaluated by echocardiography, carboxy fluorescein diacetate succinimidyl ester (CFSE) labeled cell tracing, histochemistry, qRT-PCR and western blot analysis. The co -culturing experiments were carried out for further exploring the mechanisms of hAMSCs-derived conditioned medium (CM) on macrophage polarization and fibroblast fibrosis in vitro. Results: hAMSCs transplantation significantly alleviated ISO -induced VR including cardiac hypertrophy and fibrosis with the improvements of cardiac functions. CFSE labeled hAMSCs kept an undifferentiated state in heart, indicating that hAMSCs-mediated the improvement of ISO -induced VR might be related to their paracrine effects. hAMSCs markedly inhibited ISO -induced inflammation and fibrosis, seen as the increase of M2 macrophage infiltration and the expressions of CD206 and IL -10, and the decreases of CD86, iNOS, COL3 and alpha SMA expressions in heart, suggesting that hAMSCs transplantation promoted the polarization of M2 macrophages and inhibited the polarization of M1 macrophages. Mechanically, hAMSCs-derived CM significantly increased the expressions of CD206, IL -10, Arg-1 and reduced the expressions of iNOS and IL -6 in RAW264.7 macrophages in vitro. Interestingly, RAW264.7-CM remarkably promoted the expressions of anti-inflammatory factors such as IL10, IDO, and COX2 in hAMSCs. Furthermore, the CM derived from hAMSCs pretreated with RAW264.7-CM markedly inhibited the expressions of fibrogenesis genes such as alpha SMA and COL3 in 3T3 cells. Conclusion: Our results demonstrated that hAMSCs effectively alleviated ISO -induced cardiac hypertrophy and fibrosis, and improved the cardiac functions in mice, and the underlying mechanisms might be related to inhibiting the inflammation and fibrosis during the ventricular remodeling through promoting the polarization of CD206hiIL-10hi macrophages in heart tissues. Our study strongly suggested that by taking the advantages of the potent immunosuppressive and anti-inflammatory effects, hAMSCs may provide an alternative therapeutic approach for prevention and treatment of VR clinically.

Human Amniotic MSCs-mediated Anti-Inflammation of CD206hiIL-10hi Macrophages Alleviates Isoproterenol-Induced Ventricular Remodeling in Mice.

Human amniotic MSCs-mediated anti-inflammation of CD206 hi IL-10 hi macrophages alleviates isoproterenol-induced ventricular remodeling in mice

Intravenously Administered Human Umbilical Cord-Derived Mesenchymal Stem Cell (hucmsc) Improves Cardiac Performance Following Infarction Via Immune Modulation

Menstrual Blood Stem Cells Attenuate Post-Infarction Myocardial Fibrosis Via Inhibiting Endothelial to Mesenchymal Transition (Endmt)

Human amniotic mesenchymal stem cells inhibit immune rejection injury from allogeneic mouse heart transplantation: A preliminary study on the microRNA expression

Potent immunomodulation and angiogenic effects of mesenchymal stem cells versus cardiomyocytes derived from pluripotent stem cells for treatment of heart failure

Exosomes derived from human amniotic fluid mesenchymal stem cells alleviate cardiac fibrosis via enhancing angiogenesis in vivo and in vitro

Human Embryonic Stem Cell-Derived Cardiovascular Progenitors Repair Infarcted Hearts Through Modulation of Macrophages Via Activation of Signal Transducer and Activator of Transcription 6

Effects of mesonchymal stem cells modified by human heine oxygenase-I gene on cardiac inflammatory cytokine and the ventricular remodeling

Intravenous Mesenchymal Stem Cell-Derived Exosomes Ameliorate Myocardial Inflammation in the Dilated Cardiomyopathy.

Human amnion mesenchymal stem cells attenuate atherosclerosis by modulating macrophage function to reduce immune response

Myeloid-derived suppressor cells alleviate adverse ventricular remodeling after acute myocardial infarction

Human Umbilical Cord Mesenchymal Stem Cells Alleviate Myocardial Endothelial-Mesenchymal Transition in a Rat Dilated Cardiomyopathy Model.

Mesenchymal stem cells derived from CHIR99021 and TGF‐β induction remained on the colicomentum and improved cardiac function of a rat model of acute myocardium infarction

Paracrine action mediate the antifibrotic effect of transplanted mesenchymal stem cells in a rat model of global heart failure

E0226 Effects of Bone Marrow Mesenchymal Stem Cells on Electrophysiological Function in Rats with Myocardial Infarction

Human amniotic mesenchymal stem cell-conditioned medium inhibited LPS-induced cell injury and inflammation by modulating CD14/TLR4-mediated signaling pathway in monocytes

E0227 Intracoronary Infusion of Mesenchymal Stem Cells Reduces Proarrhythmogenic Risks in Swine with Myocardial Infarction

Human Umbilical Cord Mesenchymal Stem Cells Promote Anti-Inflammation and Angiogenesis by Targeting Macrophages in a Rat Uterine Scar Model

Human embryonic stem cell-derived mesenchymal stromal cells suppress inflammation in mouse models of rheumatoid arthritis and lung fibrosis by regulating T-cell function

Down-regulation of VCAM-1 in bone mesenchymal stem cells reduces inflammatory responses and apoptosis to improve cardiac function in rat with myocardial infarction